Mechanisms of type 2 diabetes resolution after Roux-en-Y gastric bypass

Dariush Elahi, Panagis Galiatsatos, Atoosa Rabiee, Rocio Salas-Carrillo, Amin Vakilipour, Olga D. Carlson, Franca S. Angeli, Richard P. Shannon, Josephine M. Egan, Dana K. Andersen

Research output: Contribution to journalArticle

6 Scopus citations

Abstract

Background Bariatric surgery is the most effective treatment for the reduction of weight and resolution of type 2 diabetes mellitus (T2 DM). The objective of this study was to longitudinally assess hormonal and tissue responses after RYGB.

Methods Eight patients (5 with T2 DM) were studied before and after RYGB. A standardized test meal (STM) was administered before and at 1, 3, 6, 9, 12, and 15 months. Separately, a 2-hour hyperinsulinemic-euglycemic clamp (E-clamp) and a 2-hour hyperglycemic clamp (H-clamp) were performed before and at 1, 3, 6, and 12 months. Glucagon-like peptide-1 (GLP-1) was infused during the last hour of the H-clamp. Body composition was assessed with DXA methodology.

Results Enrollment body mass index was 49±3 kg/m2 (X±SE). STM glucose and insulin responses were normalized by 3 and 6 months. GLP-1 level increased dramatically at 1, 3, and 6 months, normalizing by 12 and 15 months. Insulin sensitivity (M of E-clamp) increased progressively at 3-12 months as fat mass decreased. The insulin response to glucose alone fell progressively over 12 months but the glucose clearance/metabolism (M of H-clamp) did not change significantly until 12 months. In response to GLP-1 infusion, insulin levels fell progressively throughout the 12 months.

Conclusion The early hypersecretion of GLP-1 leads to hyperinsulinemia and early normalization of glucose levels. The GLP-1 response normalizes within 1 year after surgery. Enhanced peripheral tissue sensitivity to insulin starts at 3 months and is associated with fat mass loss. β-cell sensitivity improves at 12 months and after the loss of ≈33% of excess weight. There is a tightly controlled feedback loop between peripheral tissue sensitivity and β-cell and L-cell (GLP-1) responses.

Original languageEnglish (US)
Pages (from-to)1028-1039
Number of pages12
JournalSurgery for Obesity and Related Diseases
Volume10
Issue number6
DOIs
StatePublished - Nov 1 2014

Keywords

  • Hyperglycemic clamp
  • Hyperinsulinemic-euglycemic clamp
  • RYGB
  • Standardized test meal
  • Type 2 diabetes mellitus

ASJC Scopus subject areas

  • Surgery

Fingerprint Dive into the research topics of 'Mechanisms of type 2 diabetes resolution after Roux-en-Y gastric bypass'. Together they form a unique fingerprint.

  • Cite this

    Elahi, D., Galiatsatos, P., Rabiee, A., Salas-Carrillo, R., Vakilipour, A., Carlson, O. D., Angeli, F. S., Shannon, R. P., Egan, J. M., & Andersen, D. K. (2014). Mechanisms of type 2 diabetes resolution after Roux-en-Y gastric bypass. Surgery for Obesity and Related Diseases, 10(6), 1028-1039. https://doi.org/10.1016/j.soard.2014.07.011